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IDENTIFICATION AND CHARACTERIZATION OF PREVOTELLA INTERMEDIA 17
TOLL-LIKE RECEPTOR 2 LIGANDS

By Jamie Feng-Hsia Yuan, MS
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of
Science in Physiology at Virginia Commonwealth University.

Virginia Commonwealth University, 2009

Major Director: Dr. Janina P. Lewis
Associate Professor, The Philips Institute of Oral & Craniofacial Molecular
School of Dentistry

Periodontal disease is one of the most prevalent human diseases affecting millions
of individuals. Bacteria are the trigger of the host response that then results in initiation
and progression of periodontal disease. The interactions between the host and the bacteria,
although very complex and intricate, are not well understood. Species of gram-negative
anaerobic bacteria implicated in the development of periodontal disease include
Porphyromonas gingivalis and Prevotella intermedia. The goal of our study was to
XU

identify P. intermedia surface proteins interacting with TLR2 receptor. Using Cy5-labeled
surface proteins we identified multiple proteins using our capture assay. The interaction of
three of those proteins was further characterized using recombinant forms of those
proteins. Using ELISA assay, we confirmed the TLR2-binding function of our selected
recombinant proteins at various protein amounts. Also, we confirmed the ability to
activate TLR2 signaling by challenging HEK cells overexpressing TLR2 with our
recombinant proteins and measuring the SEAP (secreted alkaline phosphatase) activity
which is a reporter gene that is under the control of an NF-KB inducible promoter. Our
results suggest that P. intermedia 17 Pin_A0326 and Pin_A0102 proteins play a role in
initiating the innate immune response by binding to TLR2. The protein encoded by a
2101-317lbp segment ofPin _A0326 shows the highest degree of signaling activity in our
HEK cells study. Also, similar results were observed using Pin_ A0324-encoded protein to
challenge the HEK cells. These results suggest that these P. intermedia surface proteins
play a role in interaction of the bacterium with host cells.

Xlll

CHAPTER 1: INTRODUCTION

1.1

Periodontal Disease
According to the National Institute of Dental and Craniofacial Research,

approximately 80% of all adults in the United States have some form of periodontal
disease. Periodontal disease can range from gingivitis where the gingival tissue is
inflamed to advanced periodontitis where there is damage to the soft tissue and bone that
support the teeth which can eventually be lost (Lamont and Jenkinson 1998). While
gingivitis is a reversible form of early periodontal disease, advanced periodontitis is
irreversible. Figure 1 illustrates a comparison of healthy versus diseased conditions
involved in periodontal disease (http://www.perio.org). Oral bacteria initiate periodontal
disease which is usually a chronic inflammatory disease (Gibson, III et al. 2006). Over
100 million individuals in the United States alone have some measurable form of
periodontal bone loss as reported in 1999. This means that periodontal disease is one of the
most common chronic infectious diseases in humans (Gibson, III et al. 2006).
Our oral cavity is inhabited by over 500 species of bacteria as mentioned in 2006
(Gibson, III et al. 2006). However in 2009, the number has been increased to
approximately 1000 bacteria species living in biological harmony within our oral cavity
(Allaker and Douglas 2009). This bacteria load does not necessarily indicate that we will
develop periodontal disease. As only a few specific bacterial species can promote the
14

progression from healthy to periodontal disease status. The most common bacterial
species linked to the development of periodontal disease is Porphyromonas gingivalis
(Gibson, III et al. 2006;Nagano et al. 2007). Other bacteria such as Fusobatrium,
nucleatum, Bacteroides forsythus, and Prevotella intermedia have also been strongly

linked to the progression of periodontal disease (Gibson, III et al. 2006;Kirikae et al.
1999). Many of the 500 species exist in commensal harmony with the host (Gibson, III et
al. 2006;Lamont and Jenkinson 1998). It is the shift of the ecological balance between the
bacterial and host factors that promotes the pathogenic potential (Gibson, III et al. 2006).
As mentioned earlier, advanced periodontal disease can result in soft tissue (gingival)
damage and hard tissue (alveolar bone) damage. This is the result of the inflammatory
mediators secreted by the host to fight the invading bacterial organisms (Bums et al.
2006;Gibson, III et al. 2006). Periodontal disease can range in severity, progression rate,
number of teeth affected, and age of individual {Lamont and Jenkinson 1998).
Bacteria along with mucus and other particles form a sticky colorless film on the
teeth called plaque. Plaque biofilm formation is essential in the initiation of periodontal
disease (Ezzo and Cutler 2003) as it causes inflammation of the gingival tissue when it is
8

9

not removed regularly. There is approximately 10 to 10 bacteria per mL saliva or mg of
plaque (Allaker and Douglas 2009).

Plaque can continue to spread from the tooth enamel

surface to irritate the gums and continue to grow below the gum line. Bacteria, such as
Prev. intermedia and P. gingivalis, in the plaque produce toxins which irritate the gums

and stimulate a chronic inflammatory response in which the body turns on itself As a
result the tissues and bone that support the teeth are broken down and the gu1ns start to
15

separate from the teeth forming periodontal pockets. These periodontal pockets containing
bacteria will deepen over time if not treated eventually will lead to tooth loss
(http://www.perio.org/consumer/2a.html;

1.2

(Kikkert et al. 2007).

Prevotella intermedia

1.2.1

Characteristics and Environmental Niches

Prevotella intermedia strain 17 is a gram-negative anaerobe that is involved in
periodontal infections. It is a black pigmented, rod shaped bacterium. The black
pigmentation is due to the heme compounds accumulating on the bacteria cell surface
(Allaker and Douglas 2009). It has been suggested that P. intermedia plays an etiological
role in gingivitis , periodontitis, and is associated with endodontic infections (Yu et al.
2006). It is also linked in individuals with pregnancy gingivitis (Yamanaka et al. 2009).
In pregnant individuals it has been linked to premature birth (Yu, Anaya, and Lewis 2007)
It is not as prevalent as P. gingivalis.
The entire genome of P. intermedia 17 has been recently sequenced by The
Institute of Genomic Research (TIGR; Rockville, MD, USA, http:/ /cmr.jcvi.org /). There
are 2,699,437bp in P. intermedia strain 17 with the GC content making up 43.47% of the
genome. There are a total of2878 genes, ofwhich 2816 genes code for protein. 50 genes
code for tRNA and 12 genes code for rRNA. This information is collected and available
from J. Craig Venter Institute (former TIGR) (http://cmr.jcvi.org/tigrscripts/CMR/shared/Genomes.cgi).
In a recent study by Takeshi Yamanaka's group, Prevotella intermedia strain 17
was shown to be capable of production of viscous materials that aid in the formation of the
16

dense meshwork-like structures around the cell creating the bacterial biofilm (Yamanaka et
al. 2009). This ability for P. intermedia 17 to form biofilm increases the chances of
establishing persistent infections (Yamanaka et al. 2009). Extrapolysaccharide (EPS) has
been identified as a main component of the biofilm extracellular matrix and serves to
protect P. intermedia l 7 from the human innate immune response (Yamanaka et al. 2009).
In particular, P. intermedia 17 can produce high amounts ofEPS with 80% of the
polysaccharides containing mannose (Yamanaka et al. 2009). This ability to produce the
biofilm was shown to be critical for the cells to be resistant to phagocytosis by neutrophils
(Yamanaka et al. 2009).

P. intermedia has been shown to carry antibiotic resistance genes and thus may be
responsible for antibiotic resistance spread among oral bacteria
(http://www .ncbi.nlm.nih .gov/sites/entrez?db =genomeprj&cmd=Retrieve&adopt =Overvie
w&list uids= l 75). In the infection process, P. intermedia colonizes early and binds to
other bacteria as well as host epithelial cells.

1.2.2

Clinical Association

The requirements for a bacterium to be considered a periodontal pathogen was
established back in 1996 according to Socransky's criteria. The conditions required that
the bacterium exist in higher numbers in disease-active sites compared to disease-inactive
sites· the elimination of the bacterium would arrest disease progression; the bacterium
'
possess virulence factors relevant to the disease process; the organism should elicit a
humoral or cellular immune response; and the animal pathogenicity testing should infer
17

disease potential (Ezzo and Cutler 2003). Once the periodontal pathogen such as P.

intermedia 17 has established itself and results in the progression of periodontal disease,
other disease conditions can result due to the periodontal disease. Periodontal disease has
been linked to low-level bacteremia, elevated white cell count, and systemic endotoxemias.
This can lead to endothelial cell integrity issues, plasma lipoprotein metabolism, blood
coagulation, and platelet function (Gibson, III et al. 2006).
It has been shown that periodontal disease is a risk factor for cardiovascular
diseases such as coronary heart disease (Dom, Leung, and Progulske-Fox 1998;Yu, Anaya,
and Lewis 2007). Also it has been implicated to increase the risk of preterm delivery of
low birth weight infants (Yu, Anaya, and Lewis 2007).

Antibiotics and mechanical

cleansing therapies have been typically used to treat periodontal disease (Mallorqui Fernandez et al. 2008;Takahashi et al. 2006). However studies have shown that P.

intermedia can easily acquire antibiotic resistance thus making the elimination difficult
(Mallorqui-Fernandez

et al. 2008). Therefore, novel therapeutic approaches are needed P.

intermedia.

18

Figure 1: Periodontal Disease. This picture shows the deterioration of the supporting
structures (soft tissue and bone) in the presence of periodontal disease . (www.perio.org)
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1.3

Innate Immunity
1.3.1

Host Response and Periodontal Disease

As mentioned previously , periodontal disease is the result of the interaction
between the plaque biofilm containing pathogenic bacteria, such as P. intermedia or P.

gingivalis , and the host's inflammatory response towards the bacterial invasion. If there is
a biological equilibrium between the two, then there is no progression towards the disease
state. However, when this equilibrium shifts towards the increased presence of P.

intermedia, for example, then the host's inflammatory response will also increase resulting
in the progression towards periodontal disease (Mahamed et al. 2005). Thus, when there is
a bacterial infection, the consequences are the result of the host's immune response to the
infection and the pathogen's ability to subvert the host response (Zhou and Amar 2007).

1.3.2

Bacteria and Host Interactions in the Oral Cavity

The interactions with the host and the bacteria are complex and these interactions
lead to the resorption of alveolar bone (Wang et al. 2007). The components of the cell wall
of certain bacteria, such as P. intermedia, can bind to host receptors such as those found on
the surface of the host ' s immune cells. Once this invasion of bacteria is recognized by the
host, a series of signal transductions occurs ultimately resulting in a host response to
invading bacteria (Figure 2). The first line of defense against invading bacteria is the
host ' s innate immune system (Kawai and Akira 2007;Zhou and Amar 2007). The first step
in the innate immune response is the recognition of these pathogens by way of their
PAMPs (pathogen-associated molecular patterns) via specific host receptors (as described
21

in the next section). A cascade of signal transduction occurs; resulting in the production of
inflammatory cytokines , interferons and upregulation of co-stimulatory molecules (Kawai
and Akira 2007) . The final part of the innate immune response is the elimination of the
bacteria (Mae et al. 2007).

1.4

Toll-Like Receptors (TLRs)
Toll-like receptors (TLRs) have been found to play an important role in the innate

immune response . TLRs are germ-line -encoded pattern recognition receptors (PRR) that
are expressed on the host's cell surface (Kikkert et al. 2007;Takeda and Akira 2005). They
recognize when there's a bacterial invasion and can signal transduction pathways to react
to the invasion (Mae et al. 2007). Presently, there have been at least 11 human TLRs
found (Kawai and Akira 2007 ;Kikkert et al. 2007). Figure 3 summarizes the TLRs and
their respective signaling ligands.
The TLRs are type I transmembrane proteins whose ectodomain are composed of
leucine-rich repeat (LRR) units (Mori et al. 2003;Zahringer et al. 2008;Kawai and Akira
2007;Takeda and Akira 2005). The LRR portions of the TLRs allows for recognition of
pathogen -associated molecular patterns (PAMPs), which allows the host to mount a
pathogen-specific immune response (Elson et al. 2007 ;Kawai and Akira 2007;Kikkert et al.
2007). The initiated signal transduction pathway will ultimately lead to the production of
inflammatory cytokines and expression of B7 co-stimulatory molecules and major
histocompatibility complex class II (MHC II). The MHC II will result in production of
antigen-specific acquired-immunity (Kikkert et al. 2007) .
22

In particular, TLR2 and TLR4 have been found to be the primary signaling
receptors for bacterial cell wall components (Kikkert et al. 2007). We will be focusing on
human TLR2 {hTLR2) because it recognizes lipoproteins and lipopeptides from the
bacterial cell walls {Takeda and Akira 2005). TLR2 can form heterophilic dimers with
TLRl and TLR6. TLR2/TLR1 dimer recognizes triacylated lipoproteins while
TLR2/TLR6 dimer recognizes diacylated lipoproteins (see Figure 3) {Takeda and Akira
2004;Takeda and Mira 2005).
Studies have also been shown that TLR2 can dimerize with non-TLRs such as
CD36 (Kawai and Mira 2007;Zahringer et al. 2008) or CD14 (Drage et al. 2009). CD36
and CD14, a GPI-anchored glycoprotein, act as accessory receptors which will enhance
recognition or delivery of ligands to TLR2 (Drage et al. 2009;Elson et al. 2007). In
particular, CD14 has been shown to interact with ligands such as Pam3CS~ (a synthetic
bacterial lipopeptide) by binding to it and delivering it to TLR2 (Drage et al. 2009) which
increases the sensitivity ofTLR2 responses by 100-fold (Drage et al. 2009).
The dimerization of the TLRs will activate the TLR2 signal transduction pathway
ultimately leading to the release ofNF-KB which will affect expression of other genes
involved in the innate immune response. These genes include those responsible for cell
death and cell survival {Li et al. 2009).
As mentioned previously, TLRs can recognize specific components of the bacterial
cell wall. TLRs are expressed on the cell surface of immune cells such as monocytes
(Gibson, III et al. 2006) macrophages (Aderem and Ulevitch 2000;Kawai and Akira
2007;Mae et al. 2007;Zhou and Amar 2007), neutrophils {Aderem and Ulevitch 2000;Mae
23

et al. 2007), dendritic cells (Kawai and Akira 2007;Mae et al. 2007) , epithelial cells, and
fibroblasts. Once a pathogen's PAMP is recognized by the TLRs, these immune cells are
activated and recruited (Gibson, III et al. 2006) to signal the production of inflammatory
mediators and cytokines and/or phagocytosis of the pathogens (Aderem and Ulevitch
2000;Takeda and Akira 2005). These immune cells are able to sense the invading bacteria
as nonself, including P AMPs (Elson et al. 2007). Innate immunity activation is important
in the development of antigen-specific adaptive immunity (Mae et al. 2007;Takeda and
Akira 2005). The activation ofTLRs is the bridge between the innate immunity response
and the adaptive immunity response (Mae et al. 2007).
The adaptive immune response is activated by macrophages once the degraded
bacterial components are presented to T cells. This will establish a protective immunity
against the pathogen (Aderem and Ulevitch 2000). It has been found that both TLR2 and
TLR4 are expressed on dendritic cells. These are the only antigen presenting cells that can
prime natve T cells towards a T helper l(Thl) or T helper 2 (Th2) responses. It has been
shown that the Th2 response is triggered by TLR2 activation and that gram-negative
bacteria mainly stimulate TLR2 (Kikkert et al. 2007).

1.5

TLR Signaling
Upon recognition of bacterial components by TLRs, such as TLR2, the TIR domain

(Toll/IL-1 receptor domain) as mention previously, will be activated and will initiate the
signal transduction pathway . Several downstream adaptors can be recruited and bind to the
TIR domain . These include MyD88 (myeloid differentiation factor 88), TRIF (TIR
24

domain-containing adaptor inducing interferon-P, TIRAP/Mal (TIR domain-containing
adaptor protein/MyD88-adaptor-like), and TRAM (TRIF-related adaptor molecules)
(Takeda 2005) . TRIF is involved in the MyD88-independent pathway leading to the
activation ofIRF-3 and NF-KB especially in TLR3 signaling (Yamamoto, Takeda, and
Akira 2004;Takeda 2005). TIRAP/Mal has been shown in knockout macrophage studies
to be essential for MyD88-dependent signaling pathway via TLR2 and TLR4 (Takeda
2005). TRAM was shown to be essential for TLR4-mediated MyD88-independent/TRIFdependent pathway (Takeda 2005).
The MyD88 adaptor molecule in particular is important to TLR2 signaling. The
signaling mechanism is outlined in Figure 4. Briefly, upon recognition of bacterial cell
wall components via TLR2, the TIR domain initiates the signaling pathway by recruitment
of the adaptor molecule MyD88 to the TIR domain. One stimulated, MyD88 recruits a Il-1
receptor-associated kinase (IRAK-4) which is a serine-threonine kinase to the TLRs
through interaction of the death domains on MyD88 and IRAK4 (Akira and Takeda 2004).
IRAK4 will hyperphosphorylate IRAK-1 which will allow the recruitment ofTRAF6
(Tumor necrosis factor receptor (TNFR)- associated factor) to the complex (Akira and
Takeda 2004). The formation of the IRAK-1, IRAK-2, and TRAF6 causes a
conformational change which releases itself from the receptor complex. Further
downstream, IKK (IKB kinase) is activated by phosphorylation leading to its degradation
which cause the release and activation ofNF-KB (Akira and Takeda 2004). The release of
sequestered NF-KB, a transcription factor, in the cytoplasm will allow it to translocate to
the nucleus to induce gene expression of inflammatory cytokines such as TNFa, IL-6, IL25

12 (Yamamoto, Takeda, and Akira 2004) and co-stimulatory molecules such as CD40
(Akira and Takeda 2004).

26

Figure 2: Bacteria-host interactions. Specific aspects of Prevotella intermedia 17,
specifically cell wall components, are recognized by TLR2 receptors on the host cell
surface. The binding of bacterial components to TLR2 receptors will initiate a signal
transduction pathway ultimately resulting in the synthesis and release o cytokines and
inflammatory mediators of the innate immune response. Adapted from Telford et al.
Nature Reviews Microbiology 4, 509-519 (July 2006) I doi:10.1038/nrmicro1443.
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Figure 3: Toll-Like Receptors (TLRs) . There are at least 11 human Toll-like receptors
(TLRs). Each TLR receptor has specific ligands it recognizes. In particular, we see that
TLR2 can heterodimerize with TLRl and TLR6 so that they can recognize differences
between triacylated and diacylated lipoproteins , respectively. (Adapted from Takeda,
Alcira 2004)
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Figure 4: TLR Signaling Pathway. This figure illustrates TLR2 signaling through a
MyD88-dependent pathway resulting in the activation ofNF-KB in the cytoplasm which
then translocates to the nucleus to affect gene expression of cytokines and co-stimulatory
molecules required for the innate immune response.
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1.6

Specific Aims of Our Study
P. intermedia is known to contribute to development and progression of

periodontitis (Yu et al. 2006). However, so far the mechanisms involved in the
pathogenesis of the bacterium remain unknown. Since host response is crucial for
development of periodontal disease and the TLR2 receptor has been demonstrated to be
indispensable for this process, identification of bacterial components interacting with the
receptor is the next logical step. Having the knowledge of the genomic sequence of P.
intermedia 17, we can apply proteomic approaches to identify such candidates. Thus the
goals of our investigations are to identify and characterize P. intermedia surface proteins
interacting with human TLR2.
Our approach was accomplished through several approaches:
1. Fluorescently labeling of P. intermedia cell surface protein thus allowing for
future detection of only surface proteins.
2. Identification of Cy5-labeled surface proteins interacting with TLR2 by capture
assay followed by MS protein identification.
3. Confirmation of the TLR2-binding function of selected proteins using ELISA
assay.
4. Confirmation of the ability of those proteins to signal through TLR2 using
HEK-BLUE™-2 Cells.
5. Determination of the TLR2-mediated signaling to the overall response of host
cells to those proteins.
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The results of our work will provide novel insights into the P. intermedia-host interaction.
Furthermore, as TLR2 is the major signaling receptor responsible for signaling for pro inflammatory cytokines, knowledge ofbacterial factors serving as triggers of the receptor
will ultimately allow us to design strategies interfering with such interaction and leading to
development of novel anti-P. intermedia treatment strategies. In the light of the
widespread antibiotic resistance in this bacterium, such treatment methods are urgently
needed .

34

Chapter 2: Materials and Methods

2.1

Bacterial Strains and Plasmids
Prevotella intermedia strain 17 was chosen for our study. This strain was provided

by Dr. Kai Leung (US Army Dental Research Detachment, Great Lakes, IL, USA). P.
intermedia is a gram-negative anaerobic pathogen that is involved in periodontal infections
and vertical bone loss (http://www.oralgen.lanl.gov /). As mentioned previously , the
genomic sequence of P. intermedia 17 is known and available on The Institute of Genomic
Research website (TIGR; Rockville, MD, USA, http://cmr.jcvi .org/). The genome is
2,699,437bp in size and contains 2878 genes, of which 2816 code for protein.
Escherichia coli strains TOPI O and BL21 (DE3) were used for cloning and for
protein expression, respectively (Invitrogen, CA, USA). Table 1 lists the strains used in
this study.

2.2

Media and Growth Conditions
P. intermedia strain 17 cultures were maintained on sheep-blood agar plates (TSA

II, 5% sheep blood ; BBL Cockeysville, MD, USA). Broth cultures were prepared in brain

heart infusion broth (BHI , Difeo Laboratories, Detroit, MI) supplemented with heroin
(5µg /mL) (Sigma-Aldrich , St. Louis, MO), yeast extract (lmg/mL) Sigma-Aldrich , St.
Louis, MO), cysteine (1mg/mL) (Sigma-Aldrich , St. Louis, MO) , and menandione
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(lµg /mL) (Sigma-Aldrich, St. Louis, MO) (enriched BHI) . P. intermedia 17 cultures were
grown in an anaerobic chamber in an artificial anaerobic atmosphere of 10% CO2, 10% H2,
80% N2.
E. coli strains were used for cloning and protein expression. They were grown
aerobically in Luria-Bertini medium (LB; Gibco , BRL Inc., Gaithersburg , MD, USA) and
on LB agar plates . Ampicillin (100µg /mL) (Sigma Chemical Co., St. Louis, MO) was
used for selection and maintenance oftransformants.

2.3

Preparation of Bacterial Cultures
P. intermedia strain 17 cells were used to isolate outer membrane proteins for

fluorescence labeling and TLR2 capture assays. P. intermedia 17 cells from blood agar
plates were used to inoculate BHI broth. The cultures were grown until they reached
logarithmic phase of growth. Following overnight incubation, this culture was diluted
(1:10 dilution). 5mL of the culture was used to inoculate IL ofBHI broth. This culture
was then incubated at 37°C until the optical density (OD66onm) reached 0.8 to 1.0.

2.4

Identification of Potential P. intermedia TLR2-bindiog surface proteins
2.4.1

Fluorescence Labeling of Bacterial Surface Proteins

P. intermedia 17 cultures were harvested by centrifugation for 30 minutes at 4°C

and 15000 xg. The cell pellets were resuspended and washed twice with IM PBS
(pH=8.5) and centrifuged each time for 20 minutes at 15000 x g at 4°C. Cell pellets were
each suspended in 1mL of IM PBS (pH=8.5). The labeling reaction involve the addition
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of 17 µL of Cy™5 (GE Healthcare, Little Chalfont Buckinghamshire, UK) and IO µL of
I 00mM tosyl lysyl chloromethyl ketone (TLCK, Sigma, St. Louis, MO) to the cell
suspension. The mixture was vortexed and the labeling reaction was incubated on ice in
the dark for I hour. The reaction was terminated by the addition of20 µL of 20 mM Llysine and then incubated for 20 minutes on ice. Labeled cell pellet was stored at -80°C
until it was ready for further use.

2.4.2

Preparation of P. intermedia Outer Membrane Proteins

The Cy5-labeled pellets were washed twice in IM PBS (pH=8.5) and centrifuged
as mentioned previously. The cell pellets were resuspended in I 0mL of IM PBS
containing 1mM TLCK. Cycled sonication using Branson 450 sonicator was used to
disrupt the cells (15second sonication on ice for four cycles). DNase (Deoxyribonuclease I
from bovine pancreas, Sigma, St. Louis, MO), RNase (Ribonuclease A from bovine
pancreas, Sigma, St. Louis, MO), and I M MgCh were added to the cell lysates and
incubated at room temperature for 1 hour to degrade nucleic acids . To remove the
unbroken cells, the cell lysates were centrifuged at 5000 x g at 4°C for 30 minutes. The
supernatant was collected, diluted with cold I 00mM sodium carbonate (pH = 11) to a final
volume of 60mL, and stirred on ice for I hour. The insoluble proteins were pelleted by
ultracentrifugation at 115000 x g at 4°C for I hour. The lysate contained our Cy5-labeled
OMPs.
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Table 1: Bacterial Strains and Plasmids Used in this Study

Bacteria
Prevotella
intermedia

Strains
17

Plasmid

Description
Parental Strain

Source
(Yu et al.
2006)

Chemically Competent cell
E. coli Top 10 containing
pEXT /CT-TO PO + RagA

In vitro gen
This Study

Escherichia
coli
One Shot Topl0
V2965

pVA2965

(1-900bp); Ampr

V2966

pVA2966

E.coli Topl0 containing
pEXT /CT-TOPO + RagA

This Study

(901-2100bp); Ampr

V2967

pVA2967

E. coli Topl0 containing
pEXT /CT-TOPO + RagA

This Study

(2100-3171 bp); Ampr

V2968

pVA2968

V2969

pVA2969

One Shot BL21
(DE3)
V2970

pVA2970

E.coli Topl0 containing
pEXT/CT-TOPO +
Pin A0l 02; Ampr
E. coli Topl0 containing
pEXT /CT-TOPO +
Pin A0324; Ampr
Chemically Competent
Cell

This Study

E. coli BL21 containing
pEXT /CT-TOPO + RagA

This Study

This Study

In vitro gen

(1-900bp) ; Ampr

V2971

pVA2971

E. coli BL21 containing
pEXT /CT-TO PO + RagA

This Study

(901-2100bp); Ampr

V2972

pVA2972

E. coli BL21 containing
pEXT/CT-TOPO + RagA

This Study

(2100-3171 bp); Ampr

V2973

pVA2973

V2974

pVA2974
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E. coli BL21 containing
pEXT/CT-TOPO +
Pin A0l 02; Ampr
E. coli BL21 containing
pEXT /CT-TOPO +
Pin A0324; Ampr

This Study

This Study

2.4.3

Capture Binding Assay for Potential P. intermedia Protein Candidates

We used ligand-coated surface activated magnetic beads to capture P. intermedia
OMPs. 60mg ofDynabeads M-270 Epoxy (Invitrogen cat. #14301, Carlsbad, CA) was
resuspended in 4mL 0. lM PBS (pH=7.4) to give an approximate concentration of 109
beads/mL, vortexed for 30 minutes, and then incubated for 10 minutes in a 37°C water
bath. The suspension was divided into 4 Eppendorftubes (lmL suspension per tube). The
beads were collected by placing the tubes on a magnet (Dynal MPC) for 2 minutes. The
supernatant was then removed leaving undisturbed beads. The beads were resuspended in
lmL 0.1 M PBS (pH =7.4), vortexed, placed on the magnet for 2 minutes, and supernatant
was discarded. The Dynabeads were resuspended again with 60µL 0.1 M PBS buffer
(pH=7.4) for use.
Dynabeads were covalently coated with the following ligands dissolved in 0. lM
PBS (pH=7.4) to a concentration of 1 mg/mL: TLR2 (R&D Systems, Inc, Minneapolis,
MN), BSA (Bovine Serum Albumin, Fisher Biotech, Fair Lawn, NJ), and Fetuin . 60µL of
each ligand was added to separate Eppendorftubes ofDynabeads.

We added 60µL of

0.lM PBS buffer (pH=7.4) to the final Eppendorftube . 60µL of 3M stock-solution of
ammonium sulfate was added to each tube. The tubes were incubated for 24 hours in a
37°C water bath with slow tilt rotation for covalent coupling of the ligands to the
Dynabeads. Then the tubes were placed on the magnet for 4 minutes for magnetic
separation and the supernatant discarded . Coated beads were washed four times with 0.1 M
PBS (pH=7.4). To removed unbound ligands, the beads were washed for 10 minutes in
0.5% Tween-20 (dissolved in 0.lM PBS, pH=7.4). The ligand-coated Dynabeads were
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resuspended in 60µL 0. lM PBS (pH=7.4). TLR2 was our targeted receptor while BSA,
Fetuin, and uncoated beads with 0.1M PBS served as negative controls.
600 µg of Cy5-labeled OMPs lysate (11 0µL at 5.5mg/mL concentration) of P.
intermedia were solubilized with 6.6 mg of Zwittergent 3-14 (Calbiochern, La Jolla, CA),

in 600µL of0. lM PBS. The prepared OMP lysate was incubated at 4°C with rotation for
24 hours . The lysate was then centrifuged at 13000 x g for 20 minutes. The supernatant
was collected which contained approximately 150µg ofOMPs/l00µL

supernatant. l00µL

of the supernatant was added to each of the ligand-coated Dynabeads and incubated for 24
hours at 4°C with rotation to capture the target OMPs for affinity-binding. The tube was
placed on a magnetic device for 4 minutes to collect the Dynabeads at the tube wall. The
supernatant was discarded. The beads were washed 3x with 1mL 0.1 PBS (pH=8.5) as
described previously to remove any unbound proteins.
The proteins that bound to the ligand-coated Dynabeads were eluted with 60µL of
2xSDS-Sample Buffer (2% SDS + 10µL 100mM DTT (DL-Dithiothreitol, Promega,
Madison, WI)) that was added to the washed Dynabeads, vortexed, and placed in boiling
water bath for 10 minutes. The tubes were placed on the magnet for 4 minutes , the
supernatant containing the purified target OMPs was transferred to clean Eppendorf tubes.
Schematic representation of our TLR2-capture assay is shown in Figure 5.
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Figure 5: TLR2 Capture Assay Using Magnetic Separation Technology . A) TLR2
receptor ligands were covalently bound to Dynabeads M-270 Expoxy and added to
Eppendorf tubes . Cy5-labeled P. intermedia 17 OMPs were added to the TLR2-bound
Dynabeads. B) The Cy5-labeled OMPs were incubated with the TLR2-bound Dynabeads
overnight for affinity-binding of our target OMPs to TLR2. C) The Eppendorftube was
placed on a magnetic device which will immobilize the TLR2-bound Dynabeads to the
walls of the tube. Those OMPs that affinity bound to the TLR2 receptor will also be
immobilized. D) The non-specific unbound proteins were removed in the supernatant. E)
The immobilized TLR2-bound Dynabeads were washed. F) Our candidate Cy5-labeled
OMPs were eluated from the beads with 2xSDS Sample buffer resulting in the release of
the bound OMPs. The OMPs eluates were used in 1D-SDS-PAGE and MS/MS analysis.
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2.4.4

SDS-PAGE

15µL of the purified target OMPs for each ligand receptor was prepared with 15µL
2xSample buffer and I0µL l00mM DTT. Samples were placed in boiling water bath for 5
minutes and centrifuged for 5 minutes at 14000 x g. We used 1xMOPS buffer for SDSP AGE using NuPAGE ® 12% Bis-Tris Gel (Invitrogen, Carlsbad, CA) at voltages ranging
from 50-lS0V. We loaded 5µL and 12µL samples to see if there's variation in the amount
ofbinding to the individual receptors.
Electrophoresis gel was scanned with Typhoon Imager showing Cy5-labeled
proteins (Figure 6). Next the same gel was stained with GelCode® Blue Stain Reagent
(ThermoScientific, Rockford, IL) and destained. The imaged GelCode® blue stained gel
was captured with Alphalmager 2000 documentation analysis system using white
transparent light (Figure 7).

2.4.5

LC-MS/MS Analysis

Aliquot of each of our purified target OMPs was prepared (30µL of OMPs binding
to TLR2, and 5µL of the OMPs binding to BSA, Fetuin, and Uncoated). Each of the
samples underwent methanol/chloroform precipitation procedures prior to submission for
LC-MSMS in-solution trypsin digestion. Briefly, 500µL dH2O, 500µL of methanol
(Fisher Scientific, Fair Lawn, NJ), and 125µL of chloroform (OmniPur, Gibbstown, NJ)
was added to each sample, centrifuged for 5 minutes at 14000 x g, supernatant removed,
then another 550µL of Methanol was added to the sample and centrifuged again. The
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supernatant was removed and the remaining methanol was allowed to evaporate. The dried
samples were sent for analysis.
From our Gel-Code Blue stained gel, we excised all visible protein bands for LCMS/MS for "in-gel" trypsin digestion. All MS/MS analysis was performed by Vladimir
Lee at the Trani Life Sciences Building at VCU.

2.5

Preparation of Recombinant OMPs
2.5.1

Primer Design

The nucleotide sequences of our protein candidates were obtained from the J. Craig
Venter Institute website (http://cmr.jcvi.org/tigr-scripts/CMRJGenomePage.cgi?org =gpi)
The nucleotide sequences of the candidate proteins were then used to design primers using
Invitrogen's OligoPerfect™ Designer
(https://tools.invitrogen.com/content.cfm?pageid=9716).

For PIN A0326 we created

primers for the entire gene and also for segments of the gene that will allow us to clone the
fragments into E. coli plasmids. The Pin_A0326 segments are as follows: Rag A 1-900,
Rag A 901-2100 , Rag A 2101-3171.

2.5.2

PCR

Using the primers we designed for each specific gene or gene segment, we
performed PCR to amplify the DNA. We used a standard PCR mixture of2µL 50mM
MgCh ,2µL genomic DNA of P. intermedia 17, lµL ofa 0.2µM mix of forward and
reverse primers for that protein, and 45µL of PCR Supermix Taq polymerase (Invitrogen ,
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Carlsbad, CA). The reaction was performed in the 2720 Thermal Cycler from Applied
Biosciences. The thermal profile used consisted of: initiation step at 94°C for 5 minutes,
denaturation step at 94°C for 1 minute, annealing step at 55°C for 80 seconds, extension
step at 72°C for 3 minutes and 50 seconds, a final extension step at 72°C for 10 minutes,
and a final hold at 4°C. This was done for 35 cycles.
Once the DNA was amplified, the PCR products were separated on a 1% agarose
gel electrophoresis using TBE buffer (Tris-Borate, National Diagnostics, Atlanta, GA) at
1OOVfor 20 minutes. The PCR products were visualized by ethidium bromide staining
(5mg/mL, 10 minutes). The I Kb plus DNA ladder (Invitrogen Co., Carlsbad, CA) was
used as the standard DNA size reference . We used the Alphalmager 2000 documentation
analysis system to visualize and document the bands on the agarose gel (Figure 8).
After visualization of PCR products and verification of DNA size, the PCR
products were purified using the MinElute PCR Purification Kit (250) Protocol (Qiagen
Sciences, Maryland). The purified PCR products DNA concentrations were measured with
NanoDrop.
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Figure 6: pEXPS-CTffOPO® Vector. Each of the PCR products from each of our
candidate genes were ligated to pEXP5-CT/fOPO® vector.
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2.5.3

TOPO® Cloning Reaction

We used Invitrogen's pEXP5 -CT/TOPO TA expression kit (Invitrogen Cat. No.
V960-06, Carlsbad, CA) to clone each PCR product into a pEXP5 -CT/TOPO® vector
(Figure 6). This kit allowed us to express of our recombinant protein fused to a c-terminal
peptide with a polyhistidine (6xHis) tag. The 6xHis allows for detection with Anti -His (cterminal) Antibody and purification of recombinant protein using metal-chelating
resin (Nickel or Cobalt). We followed the protocol provided with the kit to clone our PCR
products into the pEXP5-CT/TOPO ® vector. Briefly, we mixed 4µL of fresh PCR
product, 1µL of salt solution, 1µL ofTOPO ® vector. The mixture was incubated at room
temperature for 30 minutes and then placed on ice.

2.5.4

Transformation of One Shot® TOP 10 Competent E. Coli

The TOPO ® ligation reaction was transformed into chemically competent E. coli
(One Shot® TOP 10 chemically competent E. coli) (lnvitrogen Co., Carlsbad, CA). For
each transformation 2µL of the TOPO® cloning reaction was added to one thawed vial of
TOP 10 chemically competent E. coli and mixed gently. The transformation was
incubated on ice for 30 minutes, then heat-shocked for 30 seconds at 42°C without shaking
and transferred onto ice immediately. 250µL of S.O.C. Medium was added to the
transformation and then incubated at 37°C with shaking for 1 hour . 125µL of the
transformation mixture was spread onto LB agar plates containing 100µg/mL ampicillin
and incubated overnight at 3 7°C.
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Individual colonies were selected and analyzed for incorporation of our pEXP5 -CT
TOPO ® vector containing the desired insert. We screened for positive transformants by
using PCR amplification. We inoculated a standard PCR mixture consisting of23µL of
Platinum Supermix, lµL of the forward primer, and lµL of the reverse primer {lnvitrogen ,
Carlsbad, CA) with cells derived from individual colonies. The PCR mixture was placed
in the 2720 Thermal Cycler. The thermal profile used consisted of: initiation step at 94°C
for 10 minutes, denaturation step at 94°C for 30 seconds, annealing step at 55°C for 45
seconds, extension step at 72°C for 2 minutes, a final extension step at 72°C for IO
minutes, and a final hold at 4°C. This was done for 35 cycles.
PCR products from transformation of our various ligation mixtures were separated
on a 1% agarose gel electrophoresis using TBE {Tris-Borate) buffer at 100V for 20
minutes. The visualization of our construct was done as discussed earlier. Positive
colonies were selected and used to inoculate 7mL LB culture supplemented with
ampicillin. The culture was incubated at 37°C overnight then centrifuged at 13000 xg for 3
minutes, the supernatant discarded. Plasmids from the pelleted cells were purified using
Qiaprep® Spin Miniprep Kit (250) protocol (Qiagen Inc, Valencia, CA). We followed the
Plasmid DNA Purification using the QIAprep Spin Miniprep Kit and a Microcentrifuge
with a slight change in the elution buffer (25µL of Buffer EB instead of 50µL) to obtain a
more concentrated plasmid samples.
The plasmid concentrations were analyzed using N anoDrop. Purified plasmids
were submitted to Sanger Hall DNA Core Lab (Richmond , VA) for DNA Sequencing .
Sequences from the lab were analyzed with the program SeqMan and compared with the
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protein's nucleotide sequence from the Prevotella intermedia database on ORALGEN's
website (http://www.oralgen.lanl.gov/oralgen/bacteria/pintnew/index.html).

2.5.5

Transformation of One Shot® BL21 (DE3) E. Coli

Once the DNA sequences of each of our plasmids were confirmed, we needed to
express our recombinant proteins. We did this using One Shot® BL21 (DE3) E. coli
(Invitrogen Co., Carlsbad, CA) according to Invitrogen's transformation procedure.
Briefly, we added 1-5µL of our purified plasmids to a vial of One Shot® cells for each
protein we were expressing. The vial was incubated for 30 minutes then heat shocked at
42°C water bath with shaking, then 250µL ofS.O.C. Medium was added to each vial and
incubated at 37°C for 1 hour at 225rpm with shaking. The transformation was plated on
LB plates containing ampicillin (1 00µg/mL). The plates were incubated overnight at
37°c.
We selected individual colonies and inoculated LB media containing ampicillin
(1 00µg/mL) overnight at 37°C. Plasmids from the transformed BL21 cells were isolated

using Qiagen's Plasmid DNA Purification kit. The purified plasmids concentrations were
determined with Nanodrop and sent to VCU's DNA Core Lab for DNA sequencing.
Resulting sequences were analyzed with SeqMan and compared against known DNA
nucleotide sequence for the each protein.

50

2.5.6

Recombinant Protein Expression in E.coli BL21

Once we have confirmed our recombinant plasmid sequences , we cultured 7mL of
LB supplemented with ampicillin (1 00µg /mL) until it reached an OD 66onm= 1.0 to 1.2 at
37°C on shaker at 225rpm . This stock culture was used to inoculate IL of LB media
supplemented with ampicillin media until it reached on OD660nm= 0. 7 to 0.8 under the
same conditions. The IL culture was induced with IM IPTG (Isopropyl-f3-DThiogalactoside , Fisher Biotech, Fair Lawn , NJ) (1 µL /mL LB media) and allowed to grow
until it reached an 00 660nm= 1.0.
The cells were harvested by centrifugation at 6000rpm for 10 minutes at 4 °C. The
supernatant was removed and the cell pellet was washed two times with 0.1 M PBS and
centrifuged under the same conditions as described above. The cell pellet was stored at 20°C until it was ready for further use.

2.5. 7

Recombinant Protein Purification

Initially we had used Nickel-Agarose beads to purify our recombinant proteins.
We were unable to purify our recombinant proteins using these beads so we switched to
Talon ® Metal Affinity Resin System (Clontech , Mountain View, CA) under denaturing
conditions to purify our recombinant proteins. Briefly , we added 20mL of 1X
Equilibration/Wash Buffer (pH=8.0, 50mM sodium phosphate , 6M guanidine-HCL ,
300mM NaCl) to the pellet (from IL culture). Then we added I00µL protease inhibitors
(Protease Inhibitor Cocktail for use in purification of histidine-tagged proteins , Sigma, St.
Louis , MO) (1 :200) per 20mL Equilibration buffer. The pellet was resuspended by
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vortexing and the cells were disrupted by sonication (10 seconds, 4 times on ice). We
added DNase (40µL), RNase (4µL), and MgCh (4µL) per 20mL supernatant and incubated
at room temperature for 30 minutes. We centrifuged the mixture for 20 minutes at 14000
rpm at 4°C. We took an aliquot of this lysate crude extract for SDS-PAGE analysis. The
supernatant was transferred to a clean tube and then applied to our Talon Metal Affinity
Resin (Cobalt) column. The cobalt resins were equilibrated with IX Equilibration/Wash
buffer (pH=8.0) prior to application of lysate crude extract (supernatant). We loaded the
extract 5 times, and collected a sample of the unbound materials contained in the lysis flow
thru for SDS-PAGE analysis. We washed the column with the IX Equilibration/Wash
buffer (pH=8.0) until the Wash flow thru read zero at an absorbance ofA.=280nm by
NanoDrop. We then eluted our purified recombinant protein with 15mL of IX Imidazole
Elution Buffer (pH=7.0, 45mM sodium phosphate, 5.4M guanidine-HCl, 270mM NaCl,
150mM imidazole). The eluates were collected in 500µL fractions in Eppendorftubes.
The recombinant protein concentration of each fraction was measured using Nano Drop .
The total protein amount of each sample fraction measured by NanoDrop was
graphed (figures 16, 17, and 18). Selected eluate samples along with our samples collected
throughout the purification steps were prepared for SDS-PAGE analysis according to
protocols previously mentioned including methanol/chloroform precipitation [Figures 12,
13, 14, and 15]. The electrophoresis gel was stained with Sypro®Ruby Protein Gel Stain
(Invitrogen, Eugene, OR) and visualized using the Alphalmager (not shown). The same
gel was then stained with GelCode ®Blue, destained, and visualized under transparent
white light using Alphalmager.
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2.6

ELISA
The binding of our recombinant proteins to TLR2 was characterized using ELISA.

As a negative control we used BSA (Bovine Serum Albumin , Fisher Biotech, Fair Lawn,
NJ). Each of the proteins used was serially diluted to examine dose-dependent binding.
Recombinant proteins were immobilized on 96-well plates. Assay was done in triplicate ,
thus each dilution was plated in triplicate. The amounts of proteins used were 15 or 20µg ,
l0µg , lµg , 0.lµg, 0.0lµg , 0.00lµg, 0.0000lµg, 0.000000lµg. The plate was incubated
overnight at 4°C and then wells were washed with 0.lM PBS-Tween ®- 20 (0.05%) three
times to remove unbound proteins. I00µL ofblocking buffer [l % non-fat dry milk ( in
0. lM PBS)] was added to each well and incubated for 3 hours at 37°C and the wells of the
plate were washed again. TLR2 (50µg dry) (R&D Systems, Minneapolis, MN) was
suspended in 0. lM PBS to a final amount of 1.67µg TLR2/well and 100 µL was added to
each well. Similarly, the same amounts of the negative control, BSA, were also deposited
on our plate. Plate was incubated for 2 hours at 3 7°C and then washed three times with
0.lM PBS-Tween 20 (0.05%). l00µL ofanti-TLR2 antibody [dilution (1:500)] [N-17 sc8689 lot #1808 goat polyclonal IgG (200µg /mL), Santa Cruz Biotechnology] was added to
each of the 96-well plate. After overnight incubation at 4°C, the wells were washed with
0. lM PBS-Tween 20 (0.05%). Secondary antibody (Mouse anti-goat IgG-AP sc-2355 , lot
#c0708 AP conjugate [100 µg/mL], Santa Cruz Biotechnology) was diluted (1:1000) an<l
100 µL of the diluted secondary antibody was deposited into the TLR2 wells. The plates
were incubated for 2 hours at 37°C and then washed three times with 0. lM PBS-Tween 20
(0.05%) .
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ALP Substrate Kit (BIORAD , cat # 172-1063) was used to detect absorbance at
414nm. We followed the instructions supplied with the kit and added 100 µL of the
mixture to each well. The reaction color, which turned yellow, was determined using the
Multiskan MCC plate reader (Fisher Scientific, Fair Lawn, NJ) at a wavelength of 414nm.

2.7

Activation of HEK-BLUETM..2Cells

To determine the stimulation ofTLR2 by proteins identified in our study, we used
HEK-BLUE™-2 cells expressing TLR2. These cells were designed to study TLR2
stimulation by monitoring the activation ofNF-KB. HEK293 cells were co-transfected
with TLR2 and CD14 genes, along with an optimized SEAP (secreted alkaline
phosphatase) reporter gene which was under the control of an NF-KB-inducible promoter.
TLRl and TLR6 are endogenously expressed on the HEK293 cells. TLR2 activation was
detected using QUANTI-BLUE™ , which turned blue in the presence ofSEAP activity in
the supernatant of the cell cultures. If the identified proteins signal through TLR2, NF-KB
would be released from cytoplasmic sequestration, translocate to the nucleus , and induce
production ofSEAP resulting in the blue color reaction when using the QUANTI-BLUE™
assay. However , if the identified proteins did not signal through TLR2, then the assay
would remain pink because of the absence ofSEAP in the supernatant. Hence, NF-KB
activation is indicated and measured by the production of SEAP by the HEK cells. After a
short incubation time, a microplate reader (Multiskan MCC plate reader) was used to
measure the color reaction indicating the relative amount of SEAP activity in the
supernatant at a wavelength of 620-655nm.
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We cultured the cells following the InvivoGen 's protocol supplied with the HEKBLUE™-2 Cells (catalog #hb2-cells, InvivoGen, San Diego, CA) under aseptic conditions.
Briefly , the cells were suspended in 1mL of growth medium (DMEM, 2.5g/l glucose, 10%
fetal bovine serum) and transferred to a 25cm2 tissue culture flask containing 5mL of
growth medium and cultured at 37°C in 5% CO2 and 95% air incubator. The cell culture
was maintained in the same growth medium supplemented with IX HEK-BLUE™
Selection (InvivoGen , San Diego , CA). We used Normocin™ and Pen/Strep to keep the
HEK cells free of microbial contaminants. The growth medium was renewed every 3 days.
The cells were passaged when they were 70-80% confluent in the flask but not more than
30 times due to the decrease in efficiency of the cell. 180µL of the HEK cell suspension
was deposited in a 96-well growth plated (~50,000 cells/well).
To block the TLR2 binding sites we used MAb hTLR2, a purified monoclonal
antibody to human TLR2 (Cat #mab-htlr2, Invivo Gen, San Diego, CA). 2µL of the stock
antibody suspension (0. lmg/mL) was deposited in each well that TLR2 was to be blocked
prior to the addition of our proteins to prevent TLR2 signaling, activation ofNF-K13, and
production ofSEAP.

The plate was incubated at 37°C in a 5% CO2 ;95% air incubator for

15 minutes.
Next we added our proteins , Pin_A0102 , Pin_A0324 , and Pin_A0326 segments
(RagA 1-900, RagA 901-2100 , RagA 2101-3171) as well as positive and negative controls ,

P. gingivalis and sterile water, respectively. The proteins were serially diluted (1: 10) with
0.1 M PBS and 20µL of our serially diluted proteins were added to the wells. The protein
amounts in each serial dilution were 20µg , l0µg, lµg , 0.lµg , 0.0lµg, 0.00Iµg , 0.0000Iµg ,
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0.0000001 µg. The assay was also performed in triplicate. For the positive control, P.

gingivalis we used an MOI of 1:100 and added 12.5 µL to the corresponding wells. For the
negative control, sterile water , we added 20µL to the corresponding wells. Then we
incubated the plate at 3 7°C in a 5% CO2 and 95% air incubator for approximately 14
hours.
To another 96-well tissue culture plate, we added 160µL/well of Quanti-Blue™
reagent. Quanti-Blue™ is a colorimetric enzyme assay mix that helps to determine
secreted alkaline phosphatase (SEAP) activity in supematants of cell cultures. Then we
added 40µL from the supernatant of our induced HEK-BLUE™-2 cells. Following a 15
minute incubation period, readings were taken in 15 minute intervals for approximately 2
hours. SEAP activity was detected by determining the OD at 625-655nm with a
microplate reader {Multiskan MCC, Fisher Scientific, Fair Lawn, NJ).

2.8

Statistics
The ELISA assay and HEK cell stimulation experiments were performed in

triplicate each time. We perform the Student T-Test for each protein amount. Those that
were significant are denoted by the asterisks in Figures 19-24. We used the p-value of<
0.05 as our standard of comparison.
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CHAPTER3:RESULTS

3.1

Confirmation of Cy5-labeled P. intermedia 17 Surface Proteins

The confirmation of Cy5-labeled P. intermedia 17 surface proteins was done
previously by Dr. Natalia Akentieva (results not shown). Once the Cy5-labeling reaction
of P. intermedia 17 cells was completed, outer membrane proteins were isolated by Dr.
Akentieva and separated on ID SDS-PAGE. The gel was scanned with the Typhoon
Imager using 635nm wavelength to detect Cy5-labeled surface proteins. Several bands
were observed on the gel thus confirming the presence of fluorescently-labeled proteins.
Furthermore , the profile of the protein bands differed when compared to the profile of total
proteins present in the preparation thus confirming that only surface proteins were labeled.

3.2

Identification of P. intermedia 17 TLR2-binding Surface Proteins

Proteins selected using our TLR2 capture assay were separated on ID SDS-PAGE
gel and scanned with Typhoon Imager to visualize fluorescently labeled proteins. Figure 7
shows the fluorescently labeled OMPs bound to our respective covalently-bound receptor
ligands. In Lanes 2 and 7, there is a strong fluorescent signal detected ofTLR2-bind
OMPs. However, bands were detected in lanes containing proteins captured using our
control baits (BSA, Fetuin, and Uncoated). In the control baits, we see weaker fluorescent
signals as indicated by the bands as compared to the bands in TLR2. We expected to see
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little to no binding of the OMPs to the control baits. However, due to the presence of the
bands in the lanes containing the control baits, it is suggested that there is non-specific
binding of the OMPs to the control baits. The strong fluorescent signal in the lanes
containing proteins captured with TLR2 suggests specific binding.
The same gel was stained with GelCode® Blue and imaged (Figure 8). In Lanes 2
and 7, there is a major band between 82-l 16kDa and multiple minor bands of various
sizes. However , in lanes containing proteins captured using our control baits, we only see
the minor bands. This suggests that there is trace amounts of OMPs that bind to the
control baits non-specifically.
The fluorescent imaging of our gel is more sensitive as compared to the GelCode®
Blue stained gel due to the presence ofbands in the lanes containing our control baits . We
expected to see little or no binding to our negative controls as shown by the GelCode®
Blue stained gel (Figure 8). In the TLR2 lanes, we see a stronger signal in the fluorescent
image and also a corresponding major band in the GelCode® Blue stained gel.
The results from both images suggest non-specific binding of the OMPs to the
control baits and specific binding to TLR2 due to the stronger intensity of the fluorescent
image and the stained gel. The stained gel show only traces of OMPs binding to the
control baits of BSA, Fetuin, and uncoated as compared to those binding to TLR2.
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Figure 7: Isolation of Prevotella intermedia Strain 17 Cy5-labeled Surface Proteins on
Dynabeads coated with TLR2. The fluorescently labeled proteins bands were visualized
with the Typhoon Imager after SDS-Page electrophoresis protein separation. Lanes I and
6 are the Molecular Weight Standard Marker (which are not visual under fluorescent
imaging) . Lanes 2 and 7 show OMPS interacting with TLR2. Lanes 3 and 8 show OMPS
interacting with BSA (negative control). Lanes 4 and 9 show OMPs interacting with
Fetuin (negative control). Lanes 5 and 10 show OMPs interacting with Uncoated beads
(negative control) .
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Figure 8: Isolation of Target Cy5-Iabeled Surface Proteins on Dynabeads coated with
TLR2. The same gel as in Figure 6 was stained with GelCode® Blue to visualize the
OMPs binding to TLR2 and our negative control ligands of BSA, Fetuin, and Uncoated.
The visible bands were excised and sent for identification via LC-MS/MS in-gel trypsin
digestion. We performed this experiment using two different loads of our target OMPs
which shows increased amount of OMPs in Lane 7 as compared to Lane 2.
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Lane 1 & 6 Molecular Weight
Standard Marker
Lane 2 & 7 OMPs interacting
with TLR2
Lane 3 & 8 OMPs interacting
with BSA
(negative control)
Lane 4 & 9OMPs interacting
with Fetuin
(negative control)
Lane5&10OMPs interacting
with uncoated
beads in PBS
(negative control)

3.3

LC-MS/MS
The results from mass spectrometry will give us information in determining which

proteins to use in our study. These results show the accession numbers obtained from the

P. intermedia 17 database from the Comprehensive Microbial Resource (CMR) at
TIGR.org. This will be used to reference the proteins used in this study. The protein
probability score indicates the best probability score of peptides associated with the protein
in that the lower the score, the better the match. The delta correlation (Delta Cn) is the
difference between the normalized Xcorr of the primary and secondary matches. The
greater the difference indicates the better match. Delta Cn>O. l indicates a good match,
whereas Delta Cn>0.3 indicates a great match. The protein Sf score is the sum of peptide
Sf scores for all the peptides associated with that protein. Also in this case, the higher Sf
score value, the better the protein match. Sf score values above 0. 7 are considered good.
And finally, the Xcorr value is the cross correlation value that is computed from cross
correlation of the experimental MS/MS spectrum versus the candidate peptides in the
database. The candidate producing the highest Xcorr value is chosen as #1 by Sequest.
Table 2 shows mass spectrometry results obtained from in-solution samples
submitted for analysis. Using TLR2 to capture the Cy5-labeled proteins combined with
mass spectrometry analysis we were able to identify 15 proteins as listed in Table 2.
However, mass spectrometry was unable to identify any proteins in the in-solution samples
submitted using the control baits of BSA, Fetuin and uncoated beads. Table 3 and Table 4
show the identification of various proteins captured using TLR2 and BSA, respectively.
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From Table 2, the results were analyzed and candidate proteins for further analysis
were selected based on the protein probably score and the cross correlation score of each
protein as discussed above. These were Pin_ A0324 (hypothetical protein, MW 66226.82
D), PIN_A0102 (immunoreactive 42kD antigen PG33, putative, MW 41989.1 D), and
PIN_A0326 (RagA protein, putative, MW 116737.6 D). Table 6 also contains additional
information compiled from the Los Alamos National Laboratory Bioinformatics or
ORALGEN website (http://www.oralgen.lanl.gov/)

and J. Craig Venter Institute or TIGR

website (http://www.jcvi.org/).
The results in Table 3 show that our selected proteins were identified in the bands
from the electrophoresis gel. In Table 4, we see that there is low interaction between BSA
and Pin_A0326 while Pin_A0324 and Pin_A0102 showed significant interaction with BSA
based on our selection criteria. The red arrows in Figure 9 indicate our proteins.
Using the P. intermedia database on the ORALGEN website, a PSI-Blast search
was performed to determine if there were similarities in our selected genes to other genes
found in the bacteria database. Table 5 shows the results yielding significant similarity
using a BLAST p-value < le-5. For Pin_A0326, we see that there are four P. gingivalis
W83 genes showing significant similarity to our gene (PG0l 70, PG1242, PG0601, and
PG 1358). For Pin_ A0l 02, we found similarities to two P. gingivalis W83 genes (PG0626
and PG0627). There are also similarities to 11 genes found in Bacteroides

thetaiotaomicron VPI-5482. For Pin_A0324, there were no similarities found in P.
gingivalis W83, however five genes in B. thetaiotaomicron VPI-5482 were found to be
significantly similar.
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PIN_A0102

PIN_A0326

PIN Al049

PIN Al455

PIN A0228

PIN_Al 184

PIN_A\373

PIN A\336

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

2

3

4

5

6

7

8

9

10

11

12

13

14

15

PIN A0624

PIN AI000

PIN_A04 14

PIN A l 341

PIN Al509

' PIN A0324

TLR2

P.intermedia
17 database
Accession no .bl
PIN A0l60

I

Ligand"J

translation elongation factor Tu (tut)
{Prevote lla intermedia 17}
Peptidase family Ml 3 family {Prevotella
intermedia 17}

Hypothetical protein {Prevo tella
intermedia 17}
Hypothetical protein {Prevotella
intermedia 17}
immunoreacti ve 42kD antigen PG33,
putative {Prevotella intermedia 17}
ragA protein, putative {Prevotella
intermedia 17}
ribosomal protein LI 7 (rplQ) {Prevotella
intermedia 17}
immunoreacti ve 43 kDa antigen PG32,
putative {Prevotella intermedia 17}
hypothetical protein {Prevotella
intermedia 17}
lipoprotein , putative {Prevotella
intermedia 17}
hypothetical protein {Prevote lla
intermedia 17}
Phosphoserine aminotransferase (serC)
[2.6. 1.52] {Prevotella intermedia 17}
hypothetical protein {Prevote lla
intermedia 17}
TPR domain protein {Prevotella
lntermedia 17}
lmmunogenic 23 kDa Ii!

Predicted protein
Function

1.44E-12

4.48E-11
2 .38E-10
2.33E-09
3 .05E-07
1.86E-06
1.16E-05
1.61E-05
1.62E-05
2.02E-05
2.46E-05
1.53E-04
4.14E-04
1.53E-03
2.24E-03

y
y

y
y

y
y
y

y
y
y
y
y
y
y
y
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P(pro )ci

C;15
labeled

1.70

6.60

8.20

6.10

3.70

6.50

3.80

8 .30

11.60

7.90

11.90

8.70

18.60

16 .00

16.00

Delta
CndJ

74680.7

43888.2

26738.7

43897.4

66703 .1

39845.9

112567.0

31273 .8

15547.7

43075 .3

17995 .8

116737 .6

41989 .1

55226.82

28382.62

Predicted
mass, M. w., D

1 (1 0 0 0 0)

1 (1 0 0 0 0)

4 (4 0 0 0 0)

1 ( 1 0 0 0 0)

1 (1 0 0 0 0)

2 (1 1 0 0 0)

2 (2 0 0 0 0)

3 (3 0 0 0 0)

2 (2 0 0 0 0)

3 (3 0 0 0 0)

1 (1 0 0 0 0)

13(130000)

8 (8 0 0 0 0)

14(140000)

Peptide
(hitst >
ions
6 (6 0 0 0 0)

0.80

0.54

1.82

0.87

0.83

1.67

1.62

1.92

1.65

1.93

0.98

8.13

4.75

2.56

2.56

Sf(final
score) 0

10.13

10.12

20.18

10.16

10.13

18.17

20.16

20.20

20.18

20 .24

10.29

90 .26

50 .28

70.29

30.23

Score
Xcorr&l

Table 2: CyS-labeled P. intermedia 17 OMPs captured using TLR2 identified by LC-MS/MS analysis in-solution trypsin
digestion.
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a) Ligands - TLR2 or Control Baits of BSA , Fetuin , and Uncoated
b) Accession numbers from the Comprehensive Microbial resource (CMR) at TIGR;
c) The protein probability score-is the best probability score of peptides associated with the protein. The lower the score -the
better match is;
d) Delta Correlation-the difference between the normalized XCorrs of the primary and secondary matches . The greater
difference-th e better match is. Delta Cn> 0.1 good match, Delta Cn > 0.3 great match ;
e) The ration number of ions observed/number of ions possible. Number of ions possible-the number of ions in MS/MS
spectrum of this peptide. Acceptable number of observed peptid e ions> 1;
f) The protein Sf score is the sum of peptide Sf scores for all the peptides associated with that protein . The higher the value of
the Sf score, the better the protein match. Numbers above 0. 7 are considered good .
g) Xcorr-the cross correlation value computed from cross correlation of the experimental MS/MS spectrum vs. candidate
peptides in the database . The candidate producing the highest Xcorr value is chosen as #1 hit by Sequest.
Italic show the prot eins identified in negativ e controls.

PIN Al930

PIN A0737

PIN_A0102

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TL R2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

TLR2

I

I

1

1

2

4

4

5

7

7

8

8

8

9

10

10

hypothetical protein {Prevotella intermedia
17}
ragA protein , putativ e {Prevotella
intermedia 17}
Enolase (eno) [4.2.1.11) {Prevotella
intermedia 17}
succinyl -CoA synthase , beta subunit (sucC)
f6.2. l .5] {Prevotella intermedia 17}
immunoreactive 42 kD antigen PG33 ,
putative {PrevoteUa intermedia 17}
lipoprotein , putative {Prevotella intermedia
17}
immun oreactive 43 kDa antigen PG32 ,
putative {Prevotella intennedia 17}
ragA protein , putati ve {PrevoteUa
intermedia 17}
immunoreactive 42kD antigen PG33,
putative {Prevotella intermedia 17}
conserved hypothetical protein {Prevotella
intermedia 17}
immunoreacti ve 43 kDa antigen PG32 ,
putative {Prevotella intermedia 17}
Phosphoserine aminotransferase (serC)
[2.6. l.52] {Prevotella intermedia 17}

hypothetical protein {PrevoteUa intermedia
17}
hypothetical protein {Prevotella intennedia
17}
Ribosomal protein L7/L l2 C-terminal domain
protein {Prevot ella intermedia 17}
ragA protein , putative {Prevotella
intermedia 17}
Ohypothetical protein {Prevotella intennedia
17}

Predicted protein
Function
P(pro/'

1.84E- 10
1.56E-06
1.21E-04
2.74E-03
2.74E-03
2 .96E-12
8.08E-08
1.04E-05
1.35E-03
6.44E-14
4 .75E-03
1.18E - 11
4.72E-07
5.87E-05
2 .04E-09
2 .76E -05
4 .90E-05

Cy5
labeled

y
y
y

y
y
y

y

y
y

y
y
y

y
y
y
y

y
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* omitted band numbers indicate no proteins identified in that particular band.

PIN Al336

PIN_Al455

PIN_Al050

PIN A0102

PIN A0326

PIN_ Al455

PIN Al 184

PIN_A0326

PIN_A0160

PIN_A0323

PIN_A0326

PIN Al318

PIN_Al509

TLR2

1

P.intermedia
17 database
Accession no.bl
PIN_ A0324

Ligand"'

Band
submitted*

5 .60

14.60

17.40

2.60

1.80

15 .90

5.00

14.20

4 .20

2 .30

3.40

19.10

1.20

1.60

3.90

2.10

2.70

Delta Cn°J

39845.9

43075.3

20097 .1

41989.1

116737.6

43075.3

31273 .8

41989.1

41306 .4

47428 .2

116737.6

28382 .6

137936 .2

116737.6

62532.0

66703 .1

Predicted
mass,
M.W ., D
55226.8

2 (2 0 0 0 0)

9 (9 0 0 0 0)

2 (2 0 0 0 0)

1 (1 0 0 0 0)

2 (2 0 0 0 0)

5 (5 0 0 0 0)

1 (1 0 0 0 0)

5 (5 0 0 0 0)

1 (1 0 0 0 0)

1 (1 0 0 0 0)

3 (3 0 0 0 0)

6 (6 0 0 0 0)

1 (1 0 0 0 0)

2 (2 0 0 0 0)

1 (1 0 0 0 0)

2 (2 0 0 0 0)

ions
2 (2 0 0 0 0)

(hits)• )

Peptide

1.63

5.37

1.86

0.95

1.81

4 .29

0 .95

3.87

0 .41

0 .93

2.63

2.94

0.74

1.60

0.89

1.74

Sf
(final
score)fl
0.98

Table 3: Cy5-labeled P. intermedia 17 OMPs captured using TLR2 identified by LC-MS/MS analysis in-gel trypsin
digestion. (Figure footnote for Table 2).

20 .13

70.18

20.21

10.20

20.24

50.33

10 .19

40.31

10 .12

10.14

30.22

40.24

10 .16

20.15

10 .14

20.21

10.24

Score
Xcoir>

Band

lipoprotein, putati ve {Prevotella intermedia
hypothetical protein {Prevotella intermedia
17}
ribosoma l protein LI 7 (rplQ) {Prevotella
intermed ia 17}
hypothet ical protein {Prevotella intermedia
17}
conserved hypothetical protein {Prevote lla
intermedia 17}

PIN A045 l

PIN A0324

PIN_A0324

PIN_A l4 55

PIN_A0323

PIN_A l 184

PIN A0298

PIN_Al049

PIN A0228

PIN A I050

BSA

BSA

BSA

BSA

BSA

BSA

BSA

BSA

BSA

BSA

BSA

I

2

3

3

3

4

4

4

5

5

5

PIN_A0102

immun oreac tive43 kDa antigen PG32 ,
putati ve {Prevotella intermedia 17}
hypothetical protein {Prevotella intermedia
17}
immunoreactive 42kD antigen PG33 , putative
{Prevotella intennedia I 7}

PIN A0326

BSA

l

17}

hypothetical protein {Prevote/la intermedia
17}
hypothetical protein {Prevote/la intermedia
17}
hypothetical protein {Prevotella intermedia
17}

hypo thetical protein {Prevote/la intermedia
17}
ragA protein , putativ e {Prevote/la intermedia
17}

BSA

I

Predicted protein
Function

P.intermedia
17 database
Accessio n no.bl
PIN A0160

Ligand"'
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3.44E-08

6.44E-07

y

y

5.23E-05

5.00E-03

y

y

3.52E-10

y

2.39E-07

2.66E-12

y

y

1.15E-07

y

1.24E-07

1.66E-03

y

y

1.06E-03

y

2.02E-03

3.39E-1 0

y

y

P(pro)°'

Cy5
labeled

17.90

8.00

11.90

4.40

4.30

14.40

1.20

20.30

2.70

5.80

7.70

0.90

11.10

Delta Cn°1

20097 .1

15547.7

17995.8

31672.7

31273.8

41989.1

137936.2

43075 .3

55226 .8

55226.8

17935.4

116737.6

Predicted
mass,
M.w.,D
28382 .6

4 (4 0 0 0 0)

1 (1 0 0 0 0)

1 (1 0 0 0 0)

1 (1 0 0 0 0)

2 (2 0 0 0 0)

5 (5 0 0 0 0)

1 (1 0 0 0 0)

12 (12 0000 )

1 (1 0 0 0 0)

3 (3 0 0 0 0)

1 (1 0 0 0 0)

1 (1 0 0 0 0)

Peptide
(hits)°)
ions
5 (5 0 0 0 0)

2.46

0.94

0.98

0.86

1.40

3.54

0.70

7.27

0.98

2.92

0.60

0.94

Sf
(final
score) 0
3.56

Table 4: Cy5-labeled P. intermedia 17 OMPs captured using BSA identified by LC-MS/MS analysis in-gel trypsin
digestion. (Figure footnote for Table 2).

30.19

10.16

10.26

10.12

20.23

40.29

10.14

90.33

10.24

30.28

10.15

10.14

40.22

Score
Xcorrl

Figure 9: GelCode Blue stained SDS-PAGE gel showing proteins identified by
MS/MS analysis.

69

5µL
MW= kDa

1

182 ____.
116---+
82 ---+
62 ---+
48 ---+
37---+

2
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..

..
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12µL
4
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Pin_A0326
Pin_A0324
Pin_A0102

26---+
19 ---+
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6

7

8

9

10

Table 5: Blast Search Results: Genes from other bacterial species with significant
similarities to selected P. intermedia 17 genes
P. intermedia
17 genes
Pin- A0326

Pin - A0102

Bacteria
P. gingivalis W83

P. gingivalis W83

Bacteroides
thetaiotaomicron
VPI-5482

Pin- A0324

P. gingivalis W83

Bacteriodes
thetaiotaomicron
VPI-5482

Genes
PG0l 70 (tonB-dependent outer
membrane receptor)

BLAST pvalue
1e-113

PG1242 (tonB-linked outer
membrane receptor PG4 7

le-08

PG0601 (tonB-linked outer
membrane receptor PG 13

4e-08

PG1358 (tonB-dependent
receptor HmuR)

2e-07

PG0626 (outer membrane
protein)
PG0627 (outer membrane
protein)
BT3852
BT0418
BT2861
BT0066 (1 e-32)
BTl 791 (3e-14)
BT1511 (5e-13)
BT1501 (le-12)
BT2485 (3e-l 1)
BTl 505 (3e-10)
BT4481 (8e-l 0)
BT2442 (3e-09)
None

3e-38

BT1439
BT2269
BT0207
BT4725
BT2365
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(3e-15)
(1 e-07)
(9e-07)
(le -06)
(7e-06)

4e-19
32e-38
4e-38
6e-33
le-32
3e-14
5e-13
le-12
3e-11
3e-10
8e-10
3e-09
3e-15
le-07
9e-07
le-06
7e-06

3.4

Cloning of Genes Encoding TLR2-binding Proteins
3.4.1

PCR products

Upon determination of potential candidates for further functional studies, we
designed primers to amplify genes encoding the proteins using P. intermedia 17 genomic
DNA as a template. Once the PCR amplification was completed, we were able separate
the PCR products on a I% agarose gel. In Figure I 0, we see our molecular ladder (Lane I)
measured in base pairs. In Figure IO Panel A, the separated PCR products for the
Pin_ A0l 02, Pin_ A0324 , Pin_ A0326, and the Rag A 1-900 segment (Pin_ A0326) genes are
shown as bands on the agarose gel. The DNA nucleotide sequence size (also listed in
Table 6) of the candidate proteins were found on the ORALGEN website
(http://www.oralgen.lanl.gov/) and TIGR website (http://www.jcvi.org /). In Figure IO
Panel B, the Rag A 901-2100 (Pin_A0326) and Rag A 2101-3171 (Pin_A0326) gene
segments produce PCR products which were also separated on a 1% agarose gel.
The band in each of the lanes correctly corresponds to the size of each specific gene
or gene segment. The Pin A0326 gene contains 3 segments: RagA 1-900 (900bp). RagA
901-2100 (1200bp) , and RagA 2101-3171 (107lbp). The entire Pin_A0326 gene size was
confirmed also as 317lbp along with Pin_A0102 (l 143bp) and Pin_A0324 (1458bp).

3.4.2

Transformation of chemically competent E.coli One Shot® TOPl0

cells
Our purified PCR products were ligated into pEXP5-CT TOPO ® vector and the
recombinant plasmids were transformed into One Shot® TOPI O chemically competent E.
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coli. Individual colonies were selected from each plate and screened by PCR amplification
for incorporation of the desired DNA insert. The PCR products separated on 1% agarose
gel are shown in Figure 11. We see that all four colonies for Pin_ A0324 contained its
cloned DNA fragments (Figure 11 Panel A), while none of the colonies for Pin_A0326
incorporated its DNA fragments (Figure 11 Panel A).
Multiple attempts to transform the One Shot® TOPl 0 chemically competent E. coli
with the Pin_ A0326 cloned vector construct were unsuccessful. Thus, the Pin_ A0326
DNA sequence was cut into three separate segments: RagA 1-900, RagA 901-2100, RagA
2101-3171 (the numbers representing the nucleotide sequence and position of the gene
sequence). The cloning process was carried out with the 3 segments and the size of the
cloned DNA fragments were analyzed similarly (not shown). In Figure 11, Panel B, we
see that in the Pin_ A0l 02 screening colony 1 contained the correct size DNA insert.
Interestingly though, colony 4 had incorporated a vector but the insert was not the correct
DNA size.

3.4.3

DNA sequence verification

Plasmids isolated form the One Shot® TOPl 0 chemically competent E. coli strains
were submitted for DNA sequencing.

Using SeqMan we were able to assemble the DNA

sequences and verify them against the ORALGEN database for P. intermedia 17. The
purified plasmids from our One Shot® BL21 (DE3) E. coli were also sent for DNA
sequencing so that we can verify the sequences prior to induction of the BL21 E. coli to
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express our protein. Table I shows the recombinant plasmids made and used for this study
whose inserted DNA fragment has been confirmed through sequence analysis.

3.5

Purification of Recombinant Proteins

Once our positive colonies were identified from E. coli BL21 cells we selected
individual colonies and sent the isolated plasmids for DNA sequencing to verify the
sequence of the cloned genes. For each protein, cells from the colonies containing the
correct plasmids were induced with IPTG and used for protein purification. Samples from
each fraction were run on a ID SDS-PAGE gel. In figure 12 we see the SDS-PAGE gel
image for the Rag A 1-900 segment (Pin_A0326). Lane I contained our molecular weight
marker, Lane I shows the expressed proteins from the non-induced BL21 E. coli cells, and
Lane 2 shows the expressed proteins after IPTG-induction ofBL21 E. coli cells. The red
arrow points to the expression of our Rag A l-900bp segment after induction of with
IPTG . In Figure 13, we see the samples collected during the purification process of Rag A
1-900. Lanes 2 and 3 were from our lysate and lysis flow thru samples, respectively. Lane
6 shows a strong major band corresponding to the same molecular size of the band present
in Figure 12 Lane 3 (red arrow). For the RagA 901-2100 and RagA 2101-3171 segments
of Pin_A0326, we followed the same procedures to identify the protein segments (not
shown). The molecular weight of the individual segments of Pin_A0326 was determined
using the Protein Calculator v3.3 (http://www.scripps.edu/ ~cdputnam/protcalc.html) by
supplying the amino acid sequence for each segment. The isotopically averaged molecular
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Figure 10: PCR Products of P. intermedia 11 genes encoding putative TLR2 -binding
proteins. In Panel A, Lane 1: 1Kb Plus Ladder from In vitro gen, Carlsbad , CA; Lane 2:
Pin_A0102 (ompA) which is 1143bp in size; Lane 3: Pin_A0324 which is 1458bp in size;
Lane 4: Pin_A0326 (ragA) which is 3171bp in size; Lane 5: Rag A 1-900 segment of
Pin_A0326 which is 900bp in size. The gene size of each of the PCR products indicated
by the bands corresponds to those found in the ORALGEN database for Prevotella
intermedia. In PanelB, Lane 1: lKb Plus Ladder; Lane 2: Rag A 901-2100 segment of
Pin_A0326 which is 1200bp in size; Lane 3: Rag A 2101-3171 segment of Pin_A0326
which is 1071 bp in size.
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Panel B
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Table 6: Information for Selected Proteins Chosen for Study. Information was derived
from ORALGEN website (http ://www.oralgen.lanl.gov) and TIGR website
(http://cmr.jcvi .org0.

Pin- A0326

Gene
ID:
PI1941

Gene
Name
ragA

Pin- A0102

Pll 717

ompA

Pin- A0324

PI1940

Definition

Outer
membrane
receptor;
rag A
protein
Major outer
membrane
protein
Conserved
hypothetical
protein;
possible
outer
membrane
protein
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TIGR
Identification
ragA protein,
putative

Gene
Length
3171 bp

Molecular
Weight
116809

Immunoreactive
42kD antigen
PG33 , putative
Hypothetical
protein

1143 bp

42002

1458 bp

55234

Figure 11: Analysis of Transformants by PCR amplification. Once our PCR products
were ligated to the pEXP5-CT TOPO® vector, the recombinant plasmid was transformed
into One Shot® TOPI Ochemically competent E. coli. Four individual colonies were
selected for each OMP selected for analysis. PCR amplification of the individual colonies
for each OMP showed whether the correct recombinant plasmid was transformed into the
TO Pl OE. coli cells. In Panel A, for the Pin_A0324, we see in Lane 1: the 1Kb Plus
Ladder; Lanes 2-4 show positive results for our recombinant plasmids for Pin_ A0324
whose gene size is 1458bp. Also in Panel A, for the Pin_ A0326, we see in Lane 1: the
1Kb Plus Ladder; Lanes 2-4 show negative results for our recombinant plasmids for
Pin_A0326 whose gene size is 3171bp. In Panel B, for the Pin_A0102, we see in Lane 1:
1Kb Plus Ladder; Lane 2 shows a positive recombinant plasmid insert of gene size
1143bp; Lanes 3 and 4 show no recombinant plasmid insert; and Lane 5 show an insert,
however it was not the correct gene size.
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weight of RagA 1-900 segment is 31586.54 Da, RagA901-2100 is 44858.32 Da, and RagA
2101-3171 is 40401.23 Da. In Figures 12 and 13, the major band is estimated to be
between 37-49 kDa. This band appears to be larger in size compared to our estimated
molecular weight of 31586.54 Da for the RagA 1-900 segment. The bands for the
remaining segments of Pin_A0326 also show shifts in the molecular weight on their
respective gels (not shown).
Figure 14 shows the purification of Pin_A0102. However, the elution of the
Pin_A0102 protein yielded multiple bands on the ID SDS-PAGE gel (not shown) after we
selected fractions from the elution profile (Figure 17). In Figure 14, the gel did show a
major band between 37-49 kDa in size in Lanes 2, 3, and 4 as indicated by the black arrow.
In Lane 4, a strong band is present in the wash buffer indicating that the protein did not
strongly bind to the cobalt column. Though we could not elute a pure sample of our
protein, the wash sample contained protein at the approximate molecular weight of our
Pin_ AO102 of 42002 Da. This wash sample was submitted for LC-MS/MS analysis to
determine to the exact identity of the protein. The mass spectrometry results showed that
protein was identified as Pin_A0102 against the ORALGEN database for P. intermedia 17.
This confirmed the identity of the Pin_A0102 protein, which then was used in subsequent
cell stimulation experiments.
In Figure 15, the elution samples loaded on the SDS-PAGE gel showed major
bands in Lanes 7 and 8. This is at the approximated weight of Pin_A0324 of 55234 Da.
We used these elution samples for our cell stimulation experiments.
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From the cobalt affinity column assay, the polyhistidine (6xHis) tags ligated to
each of our recombinant proteins during the cloning process were captured by the cobalt
affinity column. After several washes, all the unbound proteins without the 6xHis tags
were removed from the column. The 6xHis tagged recombinant proteins were eluted and
collected at 500µL fractions and the result was an elution profile shown in Figures 16, 17,
18. From elution profile of Figure 14, we chose fraction E29 for the Rag A 1-900
segment, E9 for the Rag A 901-2100 segment, and E14 and E15 for the Rag A 2101-3171
segment as our samples to analyze and to use in cell stimulation experiments. Figure 18,
the elution profile shows that fractions El2 , E13, and E14 were in the same peak, therefore
these samples were combined after confirmation from the 1D SDS-P AGE gel for analysis
and use in cell stimulation experiments for Pin_A0324. We see the elution profiles for the
three segments of Pin_A0326 in figure 16 and Pin_A0102 in figure 17.
As of yet, we have not had confirmation our purified protein samples by LCMS/MS analysis for any of the proteins except for Pin_A0102. Samples have been
submitted.
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Figure 12: Expression of Rag A 1-900 segment (Pin_A0326). Lane 1 is the molecular
weight marker. Lane 2 is the non-induced BL21 E. coli cells. Lane 3 is the IPTG induced
BL21 E. coli cells. The arrow indicates the expression of our Rag A 1-900 fragment of
Pin_ A0326 after induction with IPTG in Lane 3 while there is no expression of our Rag A
1-900 fragment in Lane 2.
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Figure 13: Purification of Rag A 1-900 Recombinant Protein. After purification with
the Talon® Metal Affinity Resin System, we collected samples from each step to run an
SDS-PAGE gel to verify the molecular weight of our expressed recombinant protein
(indicated by arrow) after staining with GelCode® Blue and visualization with
Alphalmager under transparent light. Lanes 1 and 5 are our molecular markers . Lane 2:
Crude Lysate prior to application to Talon column, Lane 3: Lysis Flow thru after five loads
through the Talon column, Lane 4: Proteins in Wash Buffer after 3 washes , Lane 6: Elution
sample containing our recombinant protein. This process was applied to our other
recombinant proteins .
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5

6

Figure 14: Purification of Pin_A0102 (ompA Recombinant Protein. Lane 1: molecular
weight marker,: Lane 2: crude lysate sample prior to application to Talon column; Lane 3:
lysis flow thru ; and Lane 4: wash sample. A sample from the wash step (Lane 4) was
submitted for LC-MS/MS analysis. The analysis confirmed this sample as Pin_A0102 .
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Figure 15: Purification of Pin_ A0324 Recombinant Protein via Talon® Metal Resin
Affinity Column with Cobalt. The SDS-Page gel was stained with GelCode® Blue. Lane
1: molecular weight marker; Lane 2: the non-induced BL21 E. coli cells, Lane 3: the
IPTG-induced BL21 E. coli cells; Lane 4: the crude lysate prior to application to the cobalt
column; Lane 5: the lysis flow thru after five applications through the column; Lane 6: the
wash flow thru after three washes; Lane 7: the eluate sample E12; Lane 8: the eluate
sample in E14. We see a major band in Lane 7 and 8 indicating our Pin_A0324 protein .
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Figure 16: Elution Profiles for Pin_A0326 from the Talon® Metal Resin Affinity
Column using Cobalt. From these elution profiles, samples were selected for dialysis
against IM PBS for use in cell stimulation experiments. We chose E29 for Rag A 1-900,
E9 for Rag A 901-2100, and E14/15 for Rag A 2101-3171.
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Figure 17: Elution Profile of Pin_A0102 from Talon® Metal Resin Affinity Column
using Cobalt. We see multiple samples containing significant amounts of proteins.
However , for our cell stimulation experiments we used our LC-MS/MS analysis of our
wash (see figure 14).
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Figure 18: Elution Profile of Pin_A0324 from Talon ® Metal Resin Affinity Column
using Cobalt.
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3.6

Binding Characteristics of recombinant P. intermedia proteins to TLR2

We examined the binding of our recombinant proteins to TLR2 using ELISA.
Using the fluorescence ELISA (Enzyme-linked immunosorbent assay), we can measure the
absorbance at 414nm of any antigen/antibody complexes that will fluoresce so we can see
at what amount of protein will produce strong binding to the TLR2 ligand. In figure 19,
we characterized the binding of the three individual segments of the Pin A0326 (rag A)
protein. In the top and middle panels, we see that there is binding ofRagA 1-900 and
RagA 901-2100 respectively to TLR2. However, we see in the bottom panel ofFigure 19
the RagA 2101-31 71segment shows weaker binding compared to the other two segments
of Pin_A0326. We expected to see in our negative control, BSA, little to no binding to our
recombinant proteins which is what we see in Figures 19, 20, and 21 as shown by the
absorbance level of0 .l. These results suggest that the Pin_A0326 protein will bind
stronger in regions containing the 1-2100bp region as compared to the 2101-3171 bp
region. This allows us to narrow down the receptor binding region of Pin_A0326 to TLR2.
Figures 20 and 21 show the binding of Pin_A0102 and Pin_A0324 to TLR2,
respectively . These figures show strong binding to TLR2 as compared to BSA at all
protein amounts. Taken together, our selected proteins bind TLR2; however, because at all
recombinant protein concentrations used, the absorbance levels are relatively similar . The
binding of the Pin_A0326, Pin_A0102, and Pin_A034 has yet to be established to be
specific using lower protein concentrations for the assay.
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Figure 19: Binding Characteristic of Pin_ A0326 (Rag A) to TLR2 via ELISA. The
individual segments of the Rag A protein were investigated separately to narrow down the
region of the protein that can bind to the TLR2 ligand receptor. Top Panel: there is little to
no binding of Rag A 1-900 to TLR2 as compared to the BSA (control). Middle Panel: there
is strong binding of the Rag A 901-2100 segment to TLR2 as compared to BSA. Bottom
Panel: there is strong binding of Rag A 2101-3171 to TLR2 as compared to BSA.
(p>0.05).
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Figure 20: Binding Characteristic of Pin_A0102 (OmpA) to TLR2 via ELISA.
Pin_A0102 shows strong binding to TLR2 as compared to our control BSA. Pin A0102
binds at similar levels at the varying protein amounts. (p>0.05)
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Figure 21: Binding Characteristic of Pin_A0324 to TLR2 via ELISA. Pin A0324
shows strong binding to TLR2 as compared to our control BSA. Pin_ A0324 binds at
similar levels at the varying protein amounts. (p>0.05)
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3. 7

TLR2-mediated Signal Transduction in HEK Cells.
Varying amounts of the recombinant proteins were used to stimulate HEK cells

that were over expressing TLR2 . In addition to TLR2, small amounts ofTRLl and TLR6
were also expressed in the HEK cells. The genes for CD 14 and TLR2 were co-transfected
on HEK 293 cells along with the SEAP reporter gene under the control of the NF-KBinducible promoter allowing the study ofTLR2 signaling by monitoring the activation of
NF-KB in response to the bacterial challenge . The NF-KB-mediated gene expression is
measured as SEAP activity in the assay. We looked at the time point after 15 minutes of
incubation with the Quanti-Blue™ solution.
The positive control, P. gingivalis (PG), was used to maximally stimulate HEK
cells through TLR2. The negative control of water (H2O) was used to show no stimulation
ofHEK cells through TLR2. As shown in Figures 22, 23, and 24, the results obtained
using the selected controls were what we had expected.
Figure 22 shows the results obtained from stimulation ofHEK cells in response to
the 3 segments of Pin_A0326. Based on the ELISA results, we were expecting stimulation
ofHEK cells through TLR2 from all 3 segments; stronger stimulation using Rag Al -900
and RagA 901-3171 segments because of the higher binding results, and weaker
stimulation from the RagA 2101-3171 segment because of the lower binding results.
However this was not the case as shown in Figure 22. The strongest TLR2 mediated signal
transduction was seen in the bottom panel illustrating that the RagA 2101-3171 segment
(yellow line) showed maximal stimulation of the HEK cells. The SEAP activity detected
was at the level of our positive control when we used l0µg of the RagA 2101-3171
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segment. Also the RagA 2101-317lsegment does show SEAP activity starting just below
1µg of recombinant protein and starts to decline at with more than 10µg of protein. The
RagA 901-2100 segment did stimulate the HEK cells as shown in the middle panel
illustrating that there is some activation ofNF -KB; however the SEAP activity was much
lower as compared to that of the RagA 2101-3171 segment. It was also maximally
stimulated with 10µg of the recombinant protein. There was little no to no stimulation by
the RagA 1-900 segment as shown in the top panel. However , when amounts higher than
10µg were used the SEAP activity also starts to decline.
Comparing the amount ofSEAP activity recorded, we see that Rag A 2101-3171
had the highest absorbance at the wavelength of 690nm indicating that this may be the
major portion of the Pin_A0326 protein that binds to the TLR2 on host cells. We had
expected stimulation with all three segments, however the HEK cell stimulation
experiments show that the binding is more specific and localized to a specific portion of
the Pin_A0326 protein , in particular the gene segment of2101-3171.
In Figure 23, we see that the SEAP activity of Pin_A0102 (ompA) produces a nice
sigmoidal curve. We have maximal activity at I 0µg. The activation ofTLR2 signal
transduction by the Pin_ A0l 02 recombinant protein occurred with as little as 0.01 µg of
protein and was close to maximal at 1.0µg of protein. This suggests that Pin_A0102 is a
strong activator of the innate immune response .
In Figure 24, the SEAP activity detected from stimulation with Pin_ A0324 shows
that the HEK cells are being stimulated . However , the curve does not show maximal
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stimulation suggesting that more of the recombinant Pin_A0324 may be required to
determine maximal stimulation of the HEK cells. Pin_A0324 may not be as specific as the
other proteins examined in binding and stimulation ofTLR2.
In Figures 22, 23, 24 we see that the TLR2 blocked with MAb hTLR2 still shows
curves close to the HEK cells that did not have the TLR2 binding sites blocked . With
TLR2 blocked we expected to see curves resembling those of our negative contro l (H20)
when stimulated with each of our recombinant proteins . The MAb hTLR2 failed to
illustrate this expectation.
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Figure 22: SEAP Activity from Pin_A0326 (Rag A) Stimulation of HEK Cells.
Corresponding to the results from ELISA, we see that Rag A 901-2100 (middle panel) and
Rag 2101-3171 (bottom panel) segments of the Pin_A0326 protein can stimulate HEK
cells by binding to the TLR2 receptors that are overexpressed on these cells. The results
are dependent upon specific protein amounts. Top Panel: there little to no SEAP activity
from stimulation with Rag A 1-900 as compared to our negative control ofH2O.
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Figure 23: SEAP Activity from Pin_A0102 (OmpA) Stimulation of HEK Cells. We
see specific binding ofTLR2 receptors to the TLR2 on the HEK cells. The sigmoidal
curve shows that this is dependent on the amount of protein present to allow for
stimulation and production of downstream products . The SEAP activity is shown for
Pin A0102.
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Figure 24: SEAP Activity from Pin_A0324 Stimulation of HEK Cells. We can see
from our ELISA results that Pin A0324 can bind to TLR2 at all protein amounts. In the
HEK cell stimulation experiments, we see that stimulation by Pin_ A0324 starts at protein
amounts higher than 1µg. At these higher protein amounts , we see the amount of SEAP
activity from stimulation ofTLR2 on HEK cells.
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Chapter 4: DISCUSSION

4.1

Identification and Expression of TLR2-binding Candidate Proteins from P.
intermedia 17 for Further Characterization

Originally, four proteins were selected based on their cross correlation score and
peptide (hits) ions (Table 2). We were successfully able to clone and transform
Pin_A0324, Pin_A0102, and Pin_A0I60 in their entirety into BL21 E.coli. For
Pin_ A0326, we were able to produce PCR products encompassing the entire gene specific
DNA sequence. However, we encountered problems when transforming the TOPI0 E.coli
with the recombinant plasmids. Due to these problems, we decided to segment the
Pin_A0326 DNA nucleotide sequence into three smaller pieces which allowed us to finally
be to transform the recombinant plasmids containing the fragments into BL21 E. coli.
Also, we were able to express and purify the proteins. Due to time and material
constraints, we have not proceeded with the purification of Pin_A0160.
Identifying potential P. intermedia outer membrane proteins would help in our
assessing the specificity of recognition of bacterial cell wall components by the TLRs,
specifically TLR2 in the innate immune response. Most of the research has been
performed on P. gingivalis W83 (Mallorqui-Fernandez et al. 2008). For example, RagA
has been identified in P. gingivalis W83 and found to be co-transcribed with RagB. The
inactivation of either of these loci results in the non-expression of both proteins (Shi et al.
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2007). The interaction ofRagA with RagB in P. gingivalis have been suggested to play a
role in it' s stabilization of the cell membrane . It is also suggested that the protein
association may allow them to function as active transporters of degraded products and to
serve as a virulence factor (Nagano et al. 2007). The exact role of RagA has only been
speculated as of 2007, but they are very similar to outer membrane transporters (Shi et al.
2007). In murine studies, the inactivation of the rag locus was shown to decrease the
virulence of P. gingivalis in regards to soft tissue damage (Shi et al. 2007).

4.2

Purification of Recombinant Proteins

Initially, we used nickel-agarose beads affinity column for purification of our
recombinant proteins. However, the results of our purification did not yield sufficiently
purified recombinant protein . Then we switched our affinity column to Talon's cobalt
resin which yielded significantly better results. The Talon cobalt resins have been
suggested when compared to the Ni-NTA resins to have stricter spatial requirements for
the positioning of the histidines which prevents them from binding histidines located in
other place's other than the protein's His-tag. Ni-NTA has been shown to bind unwanted
host proteins while the Talon resins have lower affinity for binding host proteins.

4.3

Binding Characteristics of Recombinant Proteins to TLR2

Part of our research was to confirm and characterize the binding of our candidate
proteins to TLR2. Each of the proteins and protein segment examined in our study showed
binding to TLR2. The results for Pin_A0326 show that the RagA 2101-3171 segment
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showed the least amount of binding as compared to the other two segments, however it
resulted in higher stimulation of the HEK cells. Ifwe looked the sequence for Pin_A0326 ,
we may be able to produce segments that are likely to be found on the surface of the cell
wall, especially in the region gene base pair region of901-3171. This way we can narrow
down the portion of the Pin A0326 protein that would be recognized by the TLR2 on host
cells. The initial results of this study can give us insight into TLR2's recognition of
Pin_ A0326 and the signal transduction pathway even though we were not able to clone this
protein in its entirety.

4.4

Downstream Signaling in HEK Cells

When working with whole cells such as HEK cells that have over expressed TLR2,
we can see if varying amounts of recombinant protein can stimulate cytokine production
via the receptor. In our case, the production ofNF-KB was assayed by measuring the
SEAP activity at a wavelength of 690nm. Out of the proteins studied, the Pin_A0326
showed very interesting results. We were able to see that the region 2101-3171 show the
highest amount of SEAP activity compared to the other two segments. This segment could
potentially be the region required for recognition by TLR2 to signal the immune response.
The HEK cells also expressed TLRl and TLR6. Even though we blocked the
TLR2 receptor, there SEAP activity could still be detected if our recombinant proteins
signaled through TLRl and TLR6. However, the measured SEAP activity should be low.
We see that when we blocked the TLR2 receptor , the curve followed closely with the curve
for the non-blocked TLR2 receptors. There is a possibility that the antibody against TLR2
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was not successful in blocking the site of the receptor recognizing our protein or the
amount of antibody was not sufficient. The later, however, was not the case as we
increased the amount of antibody applied past the range suggested by the InvivoGen
Company . Antibodies for hTLRl and hTLR6 are not available to block these receptors at
this time. However , upon discussion with InvivoGen technical staff: they were unsure as
to why the MAb hTLR2 did not work on blocking or neutralizing the TLR2 binding sites
which resulted in the production of downstream products. They suggested using mouse
monoclonal antibody instead of the human monoclonal antibody which has been
experimentally found to better at neutralization of the human TLR2 receptor. Also , in the
future we will use HEK cells that do not overexpress TLR2 .

4.5

Future Studies
Our study began with the notion that TLR2 was important in the innate immune

response. In addition , we do not know much about P. intermedia virulence factors as most
studies were done on P. gingivalis. With this in mind we want to examine the surface
proteins of P. intermedia as potential virulence factors with the potential to be recognized
by TLR2 to initiate the innate immune response. We were able to identify multiple
candidates , but limited our findings to 3 proteins and were able to characterize them.
Future studies with macrophages can give us a better understanding as how our
Pin A0326 Pin A0324 and Pin A0l 02 proteins can be involved in the innate immune

-

'

-

'

response in primary cells.

-

We would also like to see how our proteins stimulate the wild-

type and TLR2 knockout murine cells by measuring the secreted cytokine levels and
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determining which cytokines are present in the supernatant. We can examine which
regulation of cytokine levels in each scenario. Other proteins from our LC-MS /MS
analysis can be characterized as potential virulence factors in the future.
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CHAPTER 5: CONCLUDING REMARKS

The biological significance of our study gives us novel insights into the P.
intermedia-host interaction. Identification and characterization of surface protein s of P.
intermedia gave us information on the bacterial components which could trigger the

activation of the TLR2 signal transduction pathway ultimately leading to the gene
expression of pro-inflammatory cytokines which are required as part of the innate immune
response. As mentioned TLR2 is the major signaling receptor responsible for signaling for
pro-inflammatory cytokines. Our knowledge of the bacterial factors serving as triggers of
the receptor will ultimately allow us to design strategies interfering with such interaction.
The identification of Pin_A0326, Pin_A0102, and Pin_A0324 as potential virulence
factors involved in the innate immune response helps shed light on these interactions.
Additionally , this knowledge could potentially lead to development of novel anti-P .
intermedia treatment strategies. In the light of the widespread antibiotic resistance in this

bacterium, such treatment methods are urgently needed.
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